nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—CYP2D6—Gefitinib—lung cancer	0.125	0.32	CbGbCtD
Remoxipride—HTR2A—phrenic nerve—lung cancer	0.102	0.436	CbGeAlD
Remoxipride—CYP2D6—Vinorelbine—lung cancer	0.0963	0.246	CbGbCtD
Remoxipride—CYP2D6—Erlotinib—lung cancer	0.0739	0.189	CbGbCtD
Remoxipride—CYP2D6—Vinblastine—lung cancer	0.0594	0.152	CbGbCtD
Remoxipride—HTR2A—pulmonary artery—lung cancer	0.0369	0.158	CbGeAlD
Remoxipride—CYP2D6—Doxorubicin—lung cancer	0.0365	0.0933	CbGbCtD
Remoxipride—SIGMAR1—mammary gland—lung cancer	0.0175	0.0749	CbGeAlD
Remoxipride—SIGMAR1—bronchus—lung cancer	0.00958	0.0411	CbGeAlD
Remoxipride—DRD2—respiratory system—lung cancer	0.0094	0.0403	CbGeAlD
Remoxipride—SIGMAR1—trachea—lung cancer	0.0086	0.0369	CbGeAlD
Remoxipride—SIGMAR1—cardiac atrium—lung cancer	0.00808	0.0347	CbGeAlD
Remoxipride—SIGMAR1—bone marrow—lung cancer	0.00682	0.0293	CbGeAlD
Remoxipride—HTR2A—respiratory system—lung cancer	0.0062	0.0266	CbGeAlD
Remoxipride—SIGMAR1—lung—lung cancer	0.00618	0.0265	CbGeAlD
Remoxipride—HTR2A—epithelium—lung cancer	0.00518	0.0222	CbGeAlD
Remoxipride—DRD2—lung—lung cancer	0.00499	0.0214	CbGeAlD
Remoxipride—HTR2A—trachea—lung cancer	0.00458	0.0197	CbGeAlD
Remoxipride—SIGMAR1—lymph node—lung cancer	0.00423	0.0181	CbGeAlD
Remoxipride—HTR2A—lung—lung cancer	0.00329	0.0141	CbGeAlD
Remoxipride—CYP2D6—Metabolism—GSTT1—lung cancer	9.01e-05	0.00024	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—MAP2K1—lung cancer	9.01e-05	0.00024	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APC—lung cancer	8.99e-05	0.000239	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CG—lung cancer	8.99e-05	0.000239	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—KIT—lung cancer	8.99e-05	0.000239	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—NRAS—lung cancer	8.99e-05	0.000239	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PIK3CD—lung cancer	8.95e-05	0.000238	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GCLC—lung cancer	8.91e-05	0.000237	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP2A6—lung cancer	8.91e-05	0.000237	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EGF—lung cancer	8.88e-05	0.000236	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AVP—lung cancer	8.75e-05	0.000233	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOA1—lung cancer	8.75e-05	0.000233	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—PIK3CB—lung cancer	8.73e-05	0.000232	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—KDR—lung cancer	8.67e-05	0.000231	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AVP—lung cancer	8.61e-05	0.000229	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—MAPK3—lung cancer	8.61e-05	0.000229	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PIK3CB—lung cancer	8.59e-05	0.000228	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—POMC—lung cancer	8.56e-05	0.000228	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—BRAF—lung cancer	8.45e-05	0.000225	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ENO1—lung cancer	8.44e-05	0.000225	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF1R—lung cancer	8.42e-05	0.000224	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCL8—lung cancer	8.39e-05	0.000223	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6R—lung cancer	8.35e-05	0.000222	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CREBBP—lung cancer	8.33e-05	0.000222	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF1R—lung cancer	8.29e-05	0.00022	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HES1—lung cancer	8.28e-05	0.00022	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCL8—lung cancer	8.25e-05	0.00022	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—EGFR—lung cancer	8.19e-05	0.000218	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HES1—lung cancer	8.14e-05	0.000217	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—RAF1—lung cancer	8.12e-05	0.000216	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—IL2—lung cancer	8.01e-05	0.000213	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—RAF1—lung cancer	7.99e-05	0.000212	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—KIT—lung cancer	7.98e-05	0.000212	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CG—lung cancer	7.98e-05	0.000212	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APC—lung cancer	7.98e-05	0.000212	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—NRAS—lung cancer	7.98e-05	0.000212	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAP2K1—lung cancer	7.95e-05	0.000212	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PIK3CB—lung cancer	7.92e-05	0.000211	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CD—lung cancer	7.9e-05	0.00021	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EGF—lung cancer	7.89e-05	0.00021	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—IL2—lung cancer	7.89e-05	0.00021	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—PIK3CA—lung cancer	7.83e-05	0.000208	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PIK3CB—lung cancer	7.8e-05	0.000207	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—KRAS—lung cancer	7.74e-05	0.000206	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—MAPK3—lung cancer	7.65e-05	0.000203	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCL8—lung cancer	7.62e-05	0.000203	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—POMC—lung cancer	7.6e-05	0.000202	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP2E1—lung cancer	7.57e-05	0.000201	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ERBB3—lung cancer	7.57e-05	0.000201	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—BRAF—lung cancer	7.5e-05	0.0002	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCL8—lung cancer	7.49e-05	0.000199	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NQO1—lung cancer	7.49e-05	0.000199	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ERBB3—lung cancer	7.44e-05	0.000198	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6R—lung cancer	7.41e-05	0.000197	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CREBBP—lung cancer	7.4e-05	0.000197	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL2—lung cancer	7.28e-05	0.000194	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—EGFR—lung cancer	7.27e-05	0.000194	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TERT—lung cancer	7.25e-05	0.000193	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL2—lung cancer	7.16e-05	0.00019	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TERT—lung cancer	7.13e-05	0.00019	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—PIK3CA—lung cancer	7.11e-05	0.000189	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MDM2—lung cancer	7.08e-05	0.000188	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAP2K1—lung cancer	7.07e-05	0.000188	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RAF1—lung cancer	7.05e-05	0.000188	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FGFR1—lung cancer	7.04e-05	0.000187	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CD—lung cancer	7.02e-05	0.000187	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ERBB2—lung cancer	6.98e-05	0.000186	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—PIK3CA—lung cancer	6.95e-05	0.000185	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HIF1A—lung cancer	6.93e-05	0.000184	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FGFR1—lung cancer	6.93e-05	0.000184	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CB—lung cancer	6.89e-05	0.000183	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MTOR—lung cancer	6.89e-05	0.000183	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—KRAS—lung cancer	6.87e-05	0.000183	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HIF1A—lung cancer	6.82e-05	0.000182	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—STK11—lung cancer	6.75e-05	0.00018	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOA1—lung cancer	6.69e-05	0.000178	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KDR—lung cancer	6.63e-05	0.000176	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCL8—lung cancer	6.62e-05	0.000176	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOA1—lung cancer	6.58e-05	0.000175	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HRAS—lung cancer	6.58e-05	0.000175	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KDR—lung cancer	6.53e-05	0.000174	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AKT1—lung cancer	6.39e-05	0.00017	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CASP3—lung cancer	6.33e-05	0.000169	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL2—lung cancer	6.33e-05	0.000168	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—PIK3CA—lung cancer	6.31e-05	0.000168	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—lung cancer	6.29e-05	0.000167	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MDM2—lung cancer	6.29e-05	0.000167	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RAF1—lung cancer	6.27e-05	0.000167	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTP1—lung cancer	6.25e-05	0.000166	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ERBB2—lung cancer	6.2e-05	0.000165	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCND1—lung cancer	6.17e-05	0.000164	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—JUN—lung cancer	6.15e-05	0.000164	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MTOR—lung cancer	6.12e-05	0.000163	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CB—lung cancer	6.12e-05	0.000163	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CG—lung cancer	6.11e-05	0.000163	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APC—lung cancer	6.11e-05	0.000163	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KIT—lung cancer	6.11e-05	0.000163	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—NRAS—lung cancer	6.11e-05	0.000163	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CAT—lung cancer	6.08e-05	0.000162	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EGF—lung cancer	6.04e-05	0.000161	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KIT—lung cancer	6.01e-05	0.00016	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CG—lung cancer	6.01e-05	0.00016	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APC—lung cancer	6.01e-05	0.00016	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—NRAS—lung cancer	6.01e-05	0.00016	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MMP9—lung cancer	5.99e-05	0.000159	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CDKN1A—lung cancer	5.97e-05	0.000159	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PTEN—lung cancer	5.95e-05	0.000158	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EGF—lung cancer	5.94e-05	0.000158	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ABCB1—lung cancer	5.91e-05	0.000157	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCL8—lung cancer	5.88e-05	0.000156	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—MAPK3—lung cancer	5.85e-05	0.000156	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HRAS—lung cancer	5.84e-05	0.000155	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—POMC—lung cancer	5.82e-05	0.000155	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—TYMS—lung cancer	5.81e-05	0.000154	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AKT1—lung cancer	5.81e-05	0.000154	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—MAPK3—lung cancer	5.76e-05	0.000153	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—BRAF—lung cancer	5.74e-05	0.000153	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTM1—lung cancer	5.74e-05	0.000153	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—POMC—lung cancer	5.72e-05	0.000152	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AKT1—lung cancer	5.68e-05	0.000151	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EP300—lung cancer	5.68e-05	0.000151	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6R—lung cancer	5.67e-05	0.000151	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CREBBP—lung cancer	5.66e-05	0.000151	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—BRAF—lung cancer	5.65e-05	0.00015	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CASP3—lung cancer	5.63e-05	0.00015	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL2—lung cancer	5.62e-05	0.000149	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—lung cancer	5.59e-05	0.000149	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6R—lung cancer	5.58e-05	0.000148	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CREBBP—lung cancer	5.57e-05	0.000148	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—EGFR—lung cancer	5.57e-05	0.000148	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SRC—lung cancer	5.52e-05	0.000147	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCND1—lung cancer	5.48e-05	0.000146	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—EGFR—lung cancer	5.48e-05	0.000146	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—JUN—lung cancer	5.47e-05	0.000145	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP1A1—lung cancer	5.44e-05	0.000145	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAP2K1—lung cancer	5.41e-05	0.000144	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ERCC2—lung cancer	5.4e-05	0.000144	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—VEGFA—lung cancer	5.38e-05	0.000143	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CD—lung cancer	5.37e-05	0.000143	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—STAT3—lung cancer	5.32e-05	0.000142	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	5.32e-05	0.000142	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAP2K1—lung cancer	5.32e-05	0.000142	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MMP9—lung cancer	5.32e-05	0.000141	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NRAS—lung cancer	5.31e-05	0.000141	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CDKN1A—lung cancer	5.3e-05	0.000141	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PTEN—lung cancer	5.29e-05	0.000141	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CD—lung cancer	5.28e-05	0.000141	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—KRAS—lung cancer	5.26e-05	0.00014	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PIK3CA—lung cancer	5.23e-05	0.000139	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—KRAS—lung cancer	5.17e-05	0.000138	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AKT1—lung cancer	5.16e-05	0.000137	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAPK3—lung cancer	5.09e-05	0.000135	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EP300—lung cancer	5.04e-05	0.000134	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MYC—lung cancer	4.95e-05	0.000132	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SRC—lung cancer	4.9e-05	0.00013	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EGFR—lung cancer	4.84e-05	0.000129	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PIK3CA—lung cancer	4.83e-05	0.000129	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MDM2—lung cancer	4.81e-05	0.000128	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RAF1—lung cancer	4.79e-05	0.000128	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—VEGFA—lung cancer	4.77e-05	0.000127	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	4.75e-05	0.000126	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ERBB2—lung cancer	4.74e-05	0.000126	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MDM2—lung cancer	4.73e-05	0.000126	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—STAT3—lung cancer	4.73e-05	0.000126	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RAF1—lung cancer	4.72e-05	0.000126	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NRAS—lung cancer	4.72e-05	0.000125	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MTOR—lung cancer	4.68e-05	0.000125	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CB—lung cancer	4.68e-05	0.000125	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOA1—lung cancer	4.67e-05	0.000124	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ERBB2—lung cancer	4.67e-05	0.000124	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MTOR—lung cancer	4.61e-05	0.000123	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CB—lung cancer	4.61e-05	0.000123	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—KRAS—lung cancer	4.57e-05	0.000122	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAPK3—lung cancer	4.52e-05	0.00012	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCL8—lung cancer	4.5e-05	0.00012	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HRAS—lung cancer	4.47e-05	0.000119	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCL8—lung cancer	4.43e-05	0.000118	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—HRAS—lung cancer	4.4e-05	0.000117	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MYC—lung cancer	4.39e-05	0.000117	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AKT1—lung cancer	4.35e-05	0.000116	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CASP3—lung cancer	4.31e-05	0.000115	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL2—lung cancer	4.3e-05	0.000114	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EGFR—lung cancer	4.3e-05	0.000114	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—lung cancer	4.28e-05	0.000114	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AKT1—lung cancer	4.28e-05	0.000114	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CG—lung cancer	4.26e-05	0.000113	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CASP3—lung cancer	4.24e-05	0.000113	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL2—lung cancer	4.23e-05	0.000113	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—lung cancer	4.21e-05	0.000112	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CA—lung cancer	4.2e-05	0.000112	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCND1—lung cancer	4.19e-05	0.000111	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—JUN—lung cancer	4.18e-05	0.000111	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCND1—lung cancer	4.12e-05	0.00011	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—JUN—lung cancer	4.12e-05	0.000109	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MMP9—lung cancer	4.07e-05	0.000108	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TP53—lung cancer	4.06e-05	0.000108	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—KRAS—lung cancer	4.06e-05	0.000108	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—POMC—lung cancer	4.06e-05	0.000108	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CDKN1A—lung cancer	4.05e-05	0.000108	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PTEN—lung cancer	4.05e-05	0.000108	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MMP9—lung cancer	4e-05	0.000107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CDKN1A—lung cancer	3.99e-05	0.000106	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PTEN—lung cancer	3.98e-05	0.000106	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CREBBP—lung cancer	3.95e-05	0.000105	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AKT1—lung cancer	3.95e-05	0.000105	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HRAS—lung cancer	3.88e-05	0.000103	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AKT1—lung cancer	3.88e-05	0.000103	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EP300—lung cancer	3.86e-05	0.000103	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EP300—lung cancer	3.8e-05	0.000101	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SRC—lung cancer	3.75e-05	9.98e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CD—lung cancer	3.75e-05	9.97e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CA—lung cancer	3.73e-05	9.92e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—lung cancer	3.72e-05	9.89e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALB—lung cancer	3.7e-05	9.84e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SRC—lung cancer	3.69e-05	9.82e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—VEGFA—lung cancer	3.65e-05	9.72e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—STAT3—lung cancer	3.62e-05	9.62e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NRAS—lung cancer	3.61e-05	9.6e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TP53—lung cancer	3.61e-05	9.6e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—VEGFA—lung cancer	3.6e-05	9.56e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—STAT3—lung cancer	3.56e-05	9.47e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NRAS—lung cancer	3.55e-05	9.45e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK3—lung cancer	3.46e-05	9.19e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HRAS—lung cancer	3.45e-05	9.18e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AKT1—lung cancer	3.43e-05	9.12e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK3—lung cancer	3.4e-05	9.05e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MYC—lung cancer	3.36e-05	8.94e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MYC—lung cancer	3.31e-05	8.8e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—lung cancer	3.3e-05	8.79e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EGFR—lung cancer	3.29e-05	8.75e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CB—lung cancer	3.27e-05	8.69e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PTGS2—lung cancer	3.24e-05	8.61e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EGFR—lung cancer	3.24e-05	8.61e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KRAS—lung cancer	3.11e-05	8.26e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KRAS—lung cancer	3.06e-05	8.13e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKT1—lung cancer	3.05e-05	8.1e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CA—lung cancer	2.85e-05	7.59e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PTEN—lung cancer	2.82e-05	7.51e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CA—lung cancer	2.81e-05	7.47e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TP53—lung cancer	2.76e-05	7.34e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TP53—lung cancer	2.72e-05	7.23e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—EP300—lung cancer	2.69e-05	7.16e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HRAS—lung cancer	2.64e-05	7.02e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HRAS—lung cancer	2.6e-05	6.91e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—lung cancer	2.53e-05	6.72e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—lung cancer	2.49e-05	6.61e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKT1—lung cancer	2.33e-05	6.2e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKT1—lung cancer	2.29e-05	6.1e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CA—lung cancer	1.99e-05	5.3e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AKT1—lung cancer	1.63e-05	4.33e-05	CbGpPWpGaD
